ArticleBMC women's health2025
Prevalence and determinants of medication adherence among women with hypertension attending urban primary health care facilities in Inezgane, Morocco: a cross-sectional study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCardiovascular diseases remain the leading cause of death globally, with hypertension representing a major modifiable risk factor. Medication adherence persists as a major challenge in hypertension management, particularly among women, who often face unique barriers to adherence. This study aimed to estimate the prevalence of antihypertensive medication adherence and to identify its associated factors among Moroccan women with hypertension.
methodsA cross-sectional study was conducted in January 2025 among women attending three urban primary health care facilities in Inezgane, Morocco. The 8-item Morisky Medication Adherence Scale (MMAS-8) was used to assess medication adherence. Descriptive statistics summarized participants' characteristics, and logistic regression analyses were performed to identify adherence-related factors.
resultsAmong 364 hypertensive Moroccan women with a median age of 58 years (IQR: 48-65), 53.3% were non-adherent to their antihypertensive treatment. Multivariable analyses revealed that having health insurance (AOR 1.87; CI 1.19-2.95; p = 0.007) and participation in therapeutic education sessions (AOR 2.21; CI 1.27-3.83; p = 0.005) were associated with improved adherence. Conversely, polytherapy (AOR 0.14; CI 0.06-0.30; p < 0.001) and multiple daily doses (AOR 0.35; CI 0.20-0.61; p < 0.001) were associated with lower adherence.
conclusionMore than half of the population of this study exhibited low adherence to antihypertensive medication. Multifaceted interventions, including enhanced patient education, simplified drug protocols, and improved healthcare accessibility, are required to improve adherence among Moroccan hypertensive women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.